Brief: Schnell Biopharmaceuticals to issue 12th convertible bonds worth 12 bln won

Aprogen Biologics

31/05/2016 09:28

May 31 (Reuters) - Schnell Biopharmaceuticals,Inc.  
 003060.KS  :   
     
    * Says it will issue the 12th unregistered/unsecured private 
convertible bonds, raising 12 billion won in proceeds for 
operations 
    * Maturity date of June 14, 2019, yield to maturity of 4.0 
pct and annual coupon of 2.0 pct, lump-sum redemption of 
principal on maturity date for the bonds 
    * A 100 pct conversion rate of bonds to common shares at 
7,110 won per share, and a conversion period from June 14, 2017 
to May 14, 2019 
     
     
    Source text in Korean: http://goo.gl/HyCDCl 
    Further company coverage: 003060.KS  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: lusha.zhang.reuters.com@reuters.net))